China Meheco Co., Ltd. is a state-holding company listed at Shanghai Stock Exchange, (Ticker Symbol: China Meheco; Stock Code: 600056) and its controlling shareholder is China General Technology (Group) Holding Co., Ltd., an important backbone state-owned enterprise directly administered by the central government. Upholding the tenet of "Cherishing Life and Seeking Excellence", China Meheco is dedicated to the promotion of human health and the development of pharmaceutical industry, endeavoring to become a flagship pharmaceutical enterprise in China.
China Meheco has established a comprehensive business framework that is guided by international trade, supported by pharmaceutical manufacture and coordinated by pharmaceutical commerce. Its business scope fully covers the whole industry chain, from R & D, cultivation & processing, manufacturing, distribution, logistics to international trading, academic promotion and technical service etc.
In the future, the company will focus on building sales network in both domestic and international markets for core products of modern Traditional Chinese Medicine, distinctive chemical preparation and bio-pharmaceutical preparations, to create an industrial chain which fully integrates R & D, production, sales and services. China Meheco strives to become a large-scale integrative pharmaceutical group with high position among domestic peers, and with worldwide renown for its great brand influence and high competitiveness.
China Meheco owns two post-doctoral workstations and a group of experts, including secondary prize winners of the National Prize for Progress in Science and Technology; it also owns a first-class platform in China for production and processing of APIs, distinctive preparations and modern Traditional Chinese Medicines. The corporation takes lead in R&D and production of antibiotics and anti-virus products, and also in the cultivation and processing of licorice and other herbal products.
As the traditional main channel in China for medical import and export, China Meheco maintains forefront position in international trade and special competence in government projects. The company insists on the whole-industry-chain mode of development in fields as botanicals and herbal medicine, integrating natural drug cultivation, storage, processing, sales and other industrial chains altogether. The corporation provides first-class comprehensive trading services for customers in pharmaceutical and chemical field, covering APIs, preparations, biologicals and blood products etc. The corporation devotes itself to integrated service on medical equipments, and has forged stable and sustainable partnership with world-leading manufacturers of medical equipment due to the company's strong competitive advantage in import and distribution. The bulk trading business of China Meheco involves raw material of dietary supplements, agricultural commodities and fine chemical materials, renowned for specialty in export and import of certain key products.
China Meheco has established a distribution system that takes advantage of supply chain coordination. It has established nationwide sales network and distribution channels covering important cities and provinces as Beijing, Guangdong, Jiangxi, Hubei, Henan, Hebei, Liaoning, Heilongjiang and Xinjiang, and has built up great influence and excellent brand image in these areas. The corporation owns large-scale and fully-qualified logistics center, ready and able to provide a full range of value-added services for all partners.